The Recall Desk
ModerateFDA (Devices)·Z-2071-2023·Announced 2023-07-12

SurgiMend collagen matrices recalled for endotoxin test result quality issues

TEI Biosciences recalls SurgiMend 1.0 collagen matrices due to problems with endotoxin testing procedures that may have produced inaccurate test results. 52 units were distributed nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or confirmed contamination. The issue stems from testing procedure failure in endotoxin quality assurance, making this a voluntary precautionary recall.

Plain-English summary

TEI Biosciences, Inc. is recalling SurgiMend 1.0, a collagen matrix for soft tissue reconstruction. The recalled products are available in sizes 18x12 cm Thin and 10x15 cm Thin, with 52 units distributed nationwide in the United States. The product codes are UDI-DI 606-005-003 (10381780112952) and 606-005-004 (10381780112969).

The recall was issued due to possible out-of-specification endotoxin test results caused by issues with in-process and finished goods endotoxin testing procedures. This means test results for endotoxin contamination may not accurately represent the actual endotoxin levels in the devices.

Healthcare facilities and providers using SurgiMend 1.0 for soft tissue reconstruction are affected by this recall.

The recalled product

Product
SurgiMend 1.0; Collagen Matrix for Soft Tissue Reconstruction; Rx Only; Sizes 18x12 cm Thin and 10x15 cm Thin.
Manufacturer
TEI Biosciences, Inc.
Hazard
  • endotoxin
  • testing-failure

Distribution

Distributed nationwide across the United States.